Media Contact
Amanda Galgay
Senior Director
Corporate Communications & Investor Relations
617-804-6659
amanda.galgay@peartherapeutics.com
Press Releases
- Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder December 10, 2018
- Pear Therapeutics Presents New Data on reSET® and reSET-O™ at American Academy of Addiction Psychiatry Annual Meeting and Scientific Symposium December 5, 2018
- Pear Therapeutics to Participate in Evercore ISI HEALTHCONx Conference November 20, 2018
- Sandoz and Pear Therapeutics Announce Launch of reSET® for Treatment of Patients With Substance Use Disorder November 19, 2018
- Pear Therapeutics to Participate in BTIG Biotech Conference and Stifel Healthcare Conference October 17, 2018
- Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference July 31, 2018